Evidence map›Paper›PMID 23032734›Full record

ReviewCurrent opinion in HIV and AIDS2012

Antiretrovirals and safer conception for HIV-serodiscordant couples.

Lynn T Matthews, Jennifer A Smit, Susan Cu-Uvin, Deborah Cohan

Erratum issuedAbstract readReview
In one paragraph

Review in Current opinion in HIV and AIDS, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 56 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
56citing papers in PubMed, 2 pooled it
5.8field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

56 citing papers in PubMed, 2 syntheses or guidelines pooled it, 129 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Trial
  4. Trial
  5. Trial
  6. Trial
  7. Article
  8. Article
  9. Article
  10. "Sexual and reproductive health matters · 2024
    Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. HIV-1 heterosexual transmission and association with sexually transmitted infections in the era of treatment as prevention.International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases · 2019
    Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

  • Erratum issued
5 · Who and what money

Authors and funding

4 authors at 4 institutions in 2 countries.

Lynn T MatthewsMassachusetts General Hospital, Center for Global Health and Division of Infectious Disease, Boston, USA. ltmatthe@bidmc.harvard.edu
Jennifer A Smit
Susan Cu-Uvin
Deborah Cohan
Beth Israel Deaconess Medical Center · USBrown University · USUniversity of California, San Francisco · USUniversity of the Witwatersrand · ZA

Funding

Virology CoreP30AI027763 · NIAID · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI STEVEN Grant DEEKS · 1988 to 2026
$93.6M
Periconception HIV risk reduction for HIV-discordant couples in UgandaK23MH095655 · NIMH · MASSACHUSETTS GENERAL HOSPITAL · PI MATTHEWS, LYNN T · 2011 to 2015
$854k
NIAID NIH HHS P30 AI027763NIMH NIH HHS K23 MH095655NIMH NIH HHS MH095655
6 · The paper itself

Abstract

purpose of reviewMany men and women living with HIV and their uninfected partners attempt to conceive children. HIV-prevention science can be applied to reduce sexual transmission risk while respecting couples' reproductive goals. Here we discuss antiretrovirals as prevention in the context of safer conception for HIV-serodiscordant couples. RECENT

findingsAntiretroviral therapy (ART) for the infected partner and pre-exposure prophylaxis (PrEP) for the uninfected partner reduce the risk of heterosexual HIV transmission. Several demonstration projects suggest the feasibility and acceptability of antiretroviral (ARV)s as periconception HIV-prevention for HIV-serodiscordant couples. The application of ARVs to periconception risk reduction may be limited by adherence. SUMMARY: For male-infected (M+F-) couples who cannot access sperm processing and female-infected (F+M-) couples unwilling to carry out insemination without intercourse, ART for the infected partner, PrEP for the uninfected partner, combined with treatment for sexually transmitted infections, sex limited to peak fertility, and medical male circumcision (for F+M couples) provide excellent, well tolerated options for reducing the risk of periconception HIV sexual transmission.

Indexed as

Family CharacteristicsAnti-HIV AgentsChemopreventionDisease Transmission, InfectiousFemaleFertilizationHIV InfectionsHumansMaleSexual PartnersAnti-HIV Agents

Identifiers

PMID23032734
PMCPMC3695736
OpenAlexW2077318378

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.